Mortality by causes in HIV-infected adults: comparison with the general population

被引:64
作者
Aldaz, Pablo [2 ]
Moreno-Iribas, Conchi [1 ]
Eguees, Nerea [1 ]
Irisarri, Fatima [1 ]
Floristan, Yugo [1 ]
Sola-Boneta, Julio [3 ]
Martinez-Artola, Victor
Sagredo, Mirian
Castilla, Jesus [1 ]
机构
[1] Inst Salud Publ Navarra, Pamplona 31003, Spain
[2] Ctr Salud San Juan, Serv Navarro Salud, Pamplona 31008, Spain
[3] Complejo Hosp Navarra, Pamplona 31008, Spain
关键词
ACTIVE ANTIRETROVIRAL THERAPY; ALL-CAUSE MORTALITY; PERSISTENT ROLE; UNITED-STATES; DEATH; AIDS; VIRUS; RISK; DISEASE; TRENDS;
D O I
10.1186/1471-2458-11-300
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: We compared mortality by cause of death in HIV-infected adults in the era of combined antiretroviral therapy with mortality in the general population in the same age and sex groups. Methods: Mortality by cause of death was analyzed for the period 1999-2006 in the cohort of persons aged 20-59 years diagnosed with HIV infection and residing in Navarre (Spain). This was compared with mortality from the same causes in the general population of the same age and sex using standardized mortality ratios (SMR). Results: There were 210 deaths among 1145 persons diagnosed with HIV (29.5 per 1000 person-years). About 50% of these deaths were from AIDS. Persons diagnosed with HIV infection had exceeded all-cause mortality (SMR 14.0, 95% CI 12.2 to 16.1) and non-AIDS mortality (SMR 6.9, 5.7 to 8.5). The analysis showed excess mortality from hepatic disease (SMR 69.0, 48.1 to 78.6), drug overdose or addiction (SMR 46.0, 29.2 to 69.0), suicide (SMR 9.6, 3.8 to 19.7), cancer (SMR 3.2, 1.8 to 5.1) and cardiovascular disease (SMR 3.1, 1.3 to 6.1). Mortality in HIV-infected intravenous drug users did not change significantly between the periods 1999-2002 and 2003-2006, but it declined by 56% in non-injecting drug users (P = 0.007). Conclusions: Persons with HIV infection continue to have considerable excess mortality despite the availability of effective antiretroviral treatments. However, excess mortality in the HIV patients has declined since these treatments were introduced, especially in persons without a history of intravenous drug use.
引用
收藏
页数:8
相关论文
共 35 条
[21]  
Moreno-Iribas C, 2006, An Sist Sanit Navar, V29, P399
[22]  
Moreno-Iribas C, 2004, An Sist Sanit Navar, V27, P221
[23]  
Navarro Carmen, 2006, Gac Sanit, V20, P421, DOI 10.1157/13096513
[24]   Risk of all-cause mortality associated with nonfatal AIDS and serious non-AIDS events among adults infected with HIV [J].
Neuhaus, Jacqueline ;
Angus, Brian ;
Kowalska, Justyna D. ;
La Rosa, Alberto ;
Sampson, Jim ;
Wentworth, Deborah ;
Mocroft, Amanda .
AIDS, 2010, 24 (05) :697-706
[25]   Delayed diagnosis of HIV infection in Spain [J].
Oliva, Jesus ;
Galindo, Silvia ;
Vives, Nuria ;
Arrillaga, Arantxa ;
Izquierdo, Ana ;
Nicolau, Antonio ;
Castilla, Jesus ;
Eugenia Lezaun, Maria ;
Alvarez, Mara ;
Rivas, Ana ;
Diez, Mercedes .
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2010, 28 (09) :583-589
[26]   Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection [J].
Palella, FJ ;
Delaney, KM ;
Moorman, AC ;
Loveless, MO ;
Fuhrer, J ;
Satten, GA ;
Aschman, DJ ;
Holmberg, SD .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (13) :853-860
[27]   Mortality in the highly active antiretroviral therapy era - Changing causes of death and disease in the HIV outpatient study [J].
Palella, Frank J., Jr. ;
Baker, Rose K. ;
Moorman, Anne C. ;
Chmiel, Joan S. ;
Wood, Kathleen C. ;
Brooks, John T. ;
Holmberg, Scott D. .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2006, 43 (01) :27-34
[28]   Incidence of types of cancer among HIV-Infected persons compared with the general population in the United States, 1992-2003 [J].
Patel, Pragna ;
Hanson, Debra L. ;
Sullivan, Patrick S. ;
Novak, Richard M. ;
Moorman, Anne C. ;
Tong, Tony C. ;
Holmberg, Scott D. ;
Brooks, John T. .
ANNALS OF INTERNAL MEDICINE, 2008, 148 (10) :728-U29
[29]   Effectiveness of highly active antiretroviral therapy in Spanish cohorts of HIV seroconverters:: differences by transmission category [J].
Pérez-Hoyos, S ;
del Amo, J ;
Muga, R ;
del Romero, J ;
de Olalla, PG ;
Guerrero, R ;
Hernàndez-Aguado, I .
AIDS, 2003, 17 (03) :353-359
[30]   Clinical progression of hepatitis C virus -: Related chronic liver disease in human immunodeficiency virus-infected patients undergoing highly active Antiretroviral therapy [J].
Pineda, Juan A. ;
Garcia-Garcia, Jose A. ;
Aguilar-Guisado, Manuela ;
Rios-Villegas, Maria J. ;
Ruiz-Morales, Josefa ;
Rivero, Antonio ;
del Valle, Jose ;
Luque, Rafael ;
Rodriguez-Bano, Jesus ;
Gonzolez-Serrano, Mercedes ;
Camacho, Angela ;
Macias, Juan ;
Grilo, Israel ;
Gomez-Mateos, Jesus M. .
HEPATOLOGY, 2007, 46 (03) :622-630